{"code":"C180706","name":"Abbott Architect SARS-CoV-2 IgG Serology Assay","terminology":"ncit","version":"26.09d","conceptStatus":"DEFAULT","leaf":true,"active":true,"synonyms":[{"name":"Abbott Architect SARS-CoV-2 IgG Serology Assay","termType":"PT","type":"FULL_SYN","typeCode":"P90","source":"NCI"},{"name":"Abbott Architect SARS-CoV-2 IgG Serology Assay","type":"Preferred_Name","typeCode":"P108"},{"name":"Abbott Architect SARS-CoV-2 IgG Serology Assay","termType":"PT","type":"FULL_SYN","typeCode":"P90","source":"ORCHESTRA"}],"definitions":[{"definition":"A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma on the Abbott ARCHITECT i system. The persistence of immunoglobulin class G (IgG) antibodies may identify people who have been infected in the past, recovered from the illness, and possibly developed immunity.","code":"P97","type":"DEFINITION","source":"NCI"}],"properties":[{"code":"P322","type":"Contributing_Source","value":"ORCHESTRA"},{"code":"P208","type":"NCI_META_CUI","value":"CL1663320"},{"code":"P106","type":"Semantic_Type","value":"Laboratory Procedure"}]}